医薬品営業アウトソーシングの世界市場

医薬品営業アウトソーシングの世界市場は2030年までに248億米ドルに到達

2024年に173億米ドルと推定される医薬品営業アウトソーシングの世界市場は、2024年から2030年にかけてCAGR 6.2%で成長し、2030年には248億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるパーソナル・プロモーション・サービスは、CAGR 5.4%を記録し、分析期間終了時には142億米ドルに達すると予測されます。非パーソナルプロモーションサービス分野の成長率は、分析期間中CAGR 7.1%と推定されます。

米国市場は47億米ドル、中国はCAGR9.6%で成長すると予測

米国の医薬品営業アウトソーシング市場は、2024年に47億米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGR 9.6%を牽引し、2030年までに50億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.1％と6.0％と予測されています。欧州では、ドイツがCAGR 4.1%で成長すると予測されています。

世界の医薬品営業アウトソーシング市場- 主要動向と促進要因のまとめ

市場が複雑化しマージンが圧迫される中、製薬企業が営業機能をアウトソーシングする理由とは？

医薬品営業アウトソーシング（CSO）は、大規模な社内営業チームを維持するための固定費をかけずに、商業運営の最適化、市場参入リスクの管理、医師との関係拡大を目指す医薬品メーカーにとって、戦略的なテコとして発展してきました。規制当局の監視、価格設定圧力、支払者の影響力が高まる中、製薬会社は、よりスリムで柔軟性があり、治療領域に特化したパートナー・ネットワークを求めて、営業力モデルを再評価しています。CSOは、訓練された営業担当者、KOLエンゲージメントチーム、市場参入担当者を、特定の医薬品カテゴリー、テリトリー、上市ステージに合わせてすぐに利用できます。

アウトソーシングされた営業チームは、製品の上市、ライフサイクルの延長、地域拡大、共同マーケティング提携の際に特に価値を発揮します。社内のリソースが限られている中小規模のバイオ製薬企業にとって、CSOは採用、コンプライアンス教育、CRMインフラに投資することなく、迅速なスケールアップと地域浸透を可能にします。大手製薬企業でも、コスト効率と機動性を維持するために、社内チームとアウトソーシングされたフィールドフォースリソースを組み合わせたハイブリッドモデルを採用するケースが増えています。このような業務上の柔軟性は、ますます細分化・専門化する世界製薬市場を乗り切る上で中心的な役割を果たします。

テクノロジー、規制ニーズ、マルチチャネル・エンゲージメントの動向に合わせてCSOはどのように進化しているか？

今日のCSOは、単なるフィールドセールス以上のものを提供しています。彼らは、デジタルディテーリング、テレレップサービス、インサイドセールス、看護師教育、サンプル物流、リアルタイム分析などを含む、エンドツーエンドの商業アウトソーシングソリューションを提供しています。CRMツール、AIを活用したコールプランニング、eディテーリング・プラットフォーム、医師エンゲージメント・ダッシュボードの採用は、アウトソーシング・チームが医療従事者とつながる方法を再定義しました。これらのプラットフォームは、データ主導のターゲティング、メッセージのパーソナライズ、パフォーマンスのベンチマークを可能にし、セールスフォースの生産性とROIの透明性を高めます。

サービスプロバイダーはGDPR、HIPAA、Sunshine Act、地域のプロモーションコードに対応しています。CSOは現在、トレーニング、販促資料のレビュー、有害事象報告を監督するために、社内に薬事・医療担当者を置いています。さらに、デジタル・アウトリーチ、バーチャル・エンゲージメント、直接訪問を組み合わせたオムニチャネル販売戦略は、進化する医師の行動を反映するためにCSOモデルに組み込まれています。COVID以降、遠隔でのディテーリングやハイブリッド・エンゲージメントが新たな標準となる中、技術対応、治療能力、規制対応可能なセールスフォース・モデルを提供するCSOが求められています。

どの治療領域と地域がアウトソーシングされたコマーシャル・サポートの必要性を促進しているか？

がん、糖尿病、心血管疾患、中枢神経系疾患、自己免疫疾患などの慢性疾患や専門治療領域は、CSOの配置が増加している重要な領域です。このような分野では、深い医学知識、頻繁な臨床アップデート、複雑な利害関係者のマッピングが必要とされることが多く、高度な訓練を受けた営業専門家が必要とされます。その他の特典として、一般用医薬品（OTC）ブランド、バイオシミラー、ジェネリック医薬品、ニッチな希少疾病用医薬品も、少ない商業予算でリーチとブランド認知度を最適化する販売受託モデルの恩恵を受けています。

北米は世界のCSO市場をリードしており、特に米国では市場アクセスのダイナミクス、製品の多様性、地域の複雑性がアウトソーシング・ニーズの原動力となっています。欧州は、英国、ドイツ、フランス、イタリアでCSOの存在感が大きく、価格統制や地域的なニュアンスの違いにより、自社での展開が困難な市場となっています。アジア太平洋は、特に日本、韓国、インド、中国で急成長しており、多国籍企業と国内企業の両方が地域拡大のためにCSOを利用しています。ラテンアメリカと中東は、複雑で価格に敏感な市場においてCSOモデルが拡張性を提供する、新たなフロンティアです。

医薬品CSO市場の長期的成長と戦略的差別化の原動力は何か？

医薬品営業アウトソーシング市場の成長の原動力は、商業的俊敏性、コスト抑制の必要性、医薬品パイプラインの治療的複雑性の増大です。製薬業界がブロックバスター・モデルから希少・精密治療へとシフトするにつれ、営業戦略はより集中的になり、コンプライアンスを重視し、複数の利害関係者が主導するようになっています。CSOは、リーチだけでなく、スピード、柔軟性、専門分野に精通した営業人材へのアクセスという点でも活用されています。

戦略的には、主要なCSOは治療特化、デジタルインフラ、実データ統合、医療教育や患者サポートなどの付加価値サービスに投資しています。ベンダーの統合、地理的分散、パフォーマンスベースの契約は、クライアントの期待を再構築しています。製薬企業がより迅速な事業拡大、よりスマートな関与、効率的な予算管理を目指す中、CSOは取引ベンダーから戦略的商業パートナーへと進化しつつあります。CSOモデルは、現代の製薬企業の商業化プレイブックにおいて、ますます中心的な役割を果たすようになっています。

セグメント

サービスタイプ（パーソナル・プロモーション、ノン・パーソナル・プロモーション、その他サービスタイプ）;治療領域（循環器疾患、腫瘍学、代謝性疾患、神経学、整形外科疾患、感染症、その他治療領域）;エンドユーザー（バイオ医薬品企業、医療機器企業、ジェネリック企業、その他エンドユーザー）

調査対象企業の例（全34件）

• Amplity Health
• Ashfield Engage（UDG Healthcare）
• Axxelus
• CMIC Holdings Co., Ltd.
• EPS Corporation
• EVERSANA
• Granard Pharmaceutical Sales & Marketing
• GTS Solution
• ICON plc
• inVentiv Health（Syneos Health）
• IQVIA
• MaBiCo
• Mednext Pharma Pvt. Ltd.
• Parexel International Corporation
• Pharmaforce Ireland Ltd.
• PharmaLex GmbH
• Promoveo Health
• Publicis Touchpoint Solutions, Inc.
• QFR Solutions
• Vanguard Pharma

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

無料アップデート弊社のお客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・業界団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストを含む1万4,949人のエコノミストを追跡しています。当社の16,491を超えるレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Pharmaceutical Contract Sales Outsourcing Market to Reach US$24.8 Billion by 2030

The global market for Pharmaceutical Contract Sales Outsourcing estimated at US$17.3 Billion in the year 2024, is expected to reach US$24.8 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Personal Promotion Service, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$14.2 Billion by the end of the analysis period. Growth in the Non-personal Promotion Service segment is estimated at 7.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.7 Billion While China is Forecast to Grow at 9.6% CAGR

The Pharmaceutical Contract Sales Outsourcing market in the U.S. is estimated at US$4.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$5.0 Billion by the year 2030 trailing a CAGR of 9.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.1% and 6.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Global Pharmaceutical Contract Sales Outsourcing Market - Key Trends & Drivers Summarized

Why Are Pharmaceutical Companies Outsourcing Sales Functions Amid Market Complexity and Margin Pressures?

Pharmaceutical contract sales outsourcing (CSO) has evolved into a strategic lever for drug manufacturers seeking to optimize commercial operations, manage market entry risk, and expand physician engagement without the fixed costs of maintaining large in-house sales teams. With increasing regulatory scrutiny, pricing pressure, and payer influence, pharma companies are re-evaluating their salesforce models in favor of leaner, more flexible, and therapeutic-area-specialized partner networks. CSOs offer ready access to trained sales representatives, KOL engagement teams, and market access personnel-tailored to specific drug categories, territories, or launch stages.

Outsourced sales teams are particularly valuable during product launches, lifecycle extensions, regional expansions, and co-marketing collaborations. For small- and mid-sized biopharma firms with limited internal resources, CSOs enable rapid scale-up and geographic penetration without investing in recruitment, compliance training, or CRM infrastructure. Even large pharmaceutical companies increasingly use hybrid models that combine internal teams with outsourced field force resources to maintain cost-efficiency and agility. This operational flexibility is central to navigating the increasingly fragmented and specialized global pharma market.

How Are CSOs Evolving with Technology, Regulatory Needs, and Multichannel Engagement Trends?

Today’s CSOs offer more than just field sales-they provide end-to-end commercial outsourcing solutions that include digital detailing, tele-rep services, inside sales, nurse educators, sample logistics, and real-time analytics. The adoption of CRM tools, AI-powered call planning, e-detailing platforms, and physician engagement dashboards has redefined how outsourced teams connect with healthcare professionals. These platforms enable data-driven targeting, message personalization, and performance benchmarking, increasing both salesforce productivity and ROI transparency.

Regulatory compliance remains a cornerstone of CSO operations, with service providers aligning with GDPR, HIPAA, Sunshine Act, and local promotional codes. CSOs now maintain in-house regulatory and medical affairs personnel to oversee training, promotional material review, and adverse event reporting. Furthermore, omnichannel sales strategies-combining digital outreach, virtual engagement, and in-person visits-are being built into CSO models to reflect evolving physician behavior. As remote detailing and hybrid engagement become the new norm post-COVID, CSOs that offer tech-enabled, therapeutically competent, and regulatory-ready salesforce models are in high demand.

Which Therapeutic Areas and Geographies Are Driving the Need for Outsourced Commercial Support?

Chronic and specialty therapeutic areas-such as oncology, diabetes, cardiovascular diseases, CNS disorders, and autoimmune conditions-are key domains where CSOs are increasingly deployed. These segments often require deep medical knowledge, frequent clinical updates, and complex stakeholder mapping, necessitating highly trained sales professionals. Additionally, over-the-counter (OTC) brands, biosimilars, generics, and niche orphan drugs also benefit from contract sales models to optimize reach and brand awareness with lean commercial budgets.

North America leads the global CSO market, particularly the U.S., where market access dynamics, product diversity, and regional complexity drive outsourcing needs. Europe follows with significant CSO presence in the UK, Germany, France, and Italy-markets where pricing controls and local nuances make in-house deployment less feasible. Asia-Pacific is rapidly growing, especially in Japan, South Korea, India, and China, where both MNCs and domestic firms are using CSOs for regional expansion. Latin America and the Middle East represent emerging frontiers where CSO models offer scalability in complex, price-sensitive markets.

What Is Driving Long-Term Growth and Strategic Differentiation in the Pharma CSO Market?

The growth in the pharmaceutical contract sales outsourcing market is driven by the need for commercial agility, cost containment, and the growing therapeutic complexity of drug pipelines. As the pharma industry shifts from blockbuster models to rare and precision therapies, sales strategies are becoming more focused, compliance-intensive, and multi-stakeholder driven. CSOs are being leveraged not only for reach, but also for speed, flexibility, and access to sales talent with domain expertise.

Strategically, leading CSOs are investing in therapeutic specialization, digital infrastructure, real-world data integration, and value-added services such as medical education and patient support. Vendor consolidation, geographic diversification, and performance-based contracts are reshaping client expectations. As pharma companies look to expand faster, engage smarter, and manage budgets efficiently, CSOs are evolving from transactional vendors to strategic commercial partners. The CSO model is poised to play an increasingly central role in the commercialization playbook of modern pharmaceutical enterprises.

SCOPE OF STUDY:

The report analyzes the Pharmaceutical Contract Sales Outsourcing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Service Type (Personal Promotion, Non-personal Promotion, Other Service Types); Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, Other Therapeutic Areas); End-User (Biopharmaceutical Companies, Medical Device Companies, Generic Companies, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• Amplity Health
• Ashfield Engage (UDG Healthcare)
• Axxelus
• CMIC Holdings Co., Ltd.
• EPS Corporation
• EVERSANA
• Granard Pharmaceutical Sales & Marketing
• GTS Solution
• ICON plc
• inVentiv Health (Syneos Health)
• IQVIA
• MaBiCo
• Mednext Pharma Pvt. Ltd.
• Parexel International Corporation
• Pharmaforce Ireland Ltd.
• PharmaLex GmbH
• Promoveo Health
• Publicis Touchpoint Solutions, Inc.
• QFR Solutions
• Vanguard Pharma

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Pharmaceutical Contract Sales Outsourcing - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Growing Complexity in Pharmaceutical Commercialization Models Propels Demand for Contract Sales Outsourcing
  • Expansion of Specialty Drug Portfolios and Orphan Drug Launches Strengthens Business Case for Field Force Flexibility
  • Rising Cost Pressures in Pharma Marketing Strategies Throw the Spotlight on Outsourced Sales Efficiency
  • Increased Use of Hybrid and Virtual Sales Models Accelerates Demand for Digitally Enabled CSO Capabilities
  • Surge in Post-Patent Generic Competition Spurs Rapid Sales Deployment Through Contract Sales Teams
  • OEM-Partner Collaborations With Regional CSOs Enhance Market Entry in Fragmented Emerging Markets
  • Integration of AI-Driven CRM Tools and Call Analytics Improves Rep Effectiveness and ROI Tracking
  • Shift Toward Key Account Management Models Drives Strategic Alignment Between Brand and Outsourced Teams
  • Rising Emphasis on Compliance and Regulatory Audit Preparedness Enhances Need for Certified Sales Reps
  • Growth in Medical Devices and Diagnostics Portfolios Expands CSO Application Beyond Pharmaceuticals
  • Availability of Therapeutic Area-Specific Sales Forces Enables Rapid Upskilling and Niche Market Penetration
  • Increased Demand for Sales Support During Product Launches and Lifecycle Transitions Fuels Project-Based CSO Engagement
  • Expansion of Tele-Detailing and Remote Sampling Programs Sustains Outreach in Restricted Access Environments
  • Use of Omnichannel Engagement Models in Outsourced Sales Enhances Patient and HCP Targeting Precision
  • Rising Importance of Multilingual Sales Teams Supports Cross-Regional Brand Expansion in Global Markets
  • CSO Adoption by Mid-Size and Emerging Biopharma Firms Accelerates Go-To-Market Agility
  • Availability of Analytics-Backed Incentive Programs Improves Rep Motivation and Territory Performance
  • Increased Focus on Outsourced Market Access and Payer Engagement Capabilities Complements Field Sales
  • Emergence of Flexible Contracting and Subscription Models Supports Demand Variability and Budget Control
  • Rising Scrutiny of Commercial Compliance and Fair Market Value Drives Structured CSO Oversight Mechanisms
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Pharmaceutical Contract Sales Outsourcing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Pharmaceutical Contract Sales Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Personal Promotion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Personal Promotion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Personal Promotion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Non-personal Promotion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Non-personal Promotion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Non-personal Promotion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Other Service Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Other Service Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Other Service Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Other Therapeutic Areas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Cardiovascular Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Cardiovascular Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Cardiovascular Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Metabolic Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Metabolic Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Metabolic Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Orthopedic Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Orthopedic Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Orthopedic Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Biopharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Medical Device Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Generic Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Generic Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Generic Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Pharmaceutical Contract Sales Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 47: USA Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Service Type - Percentage Breakdown of Value Sales for Personal Promotion, Non-personal Promotion and Other Service Types for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: USA 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by End-user - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Service Type - Percentage Breakdown of Value Sales for Personal Promotion, Non-personal Promotion and Other Service Types for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Canada 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by End-user - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users for the Years 2015, 2025 & 2030
• JAPAN
  • Pharmaceutical Contract Sales Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Service Type - Percentage Breakdown of Value Sales for Personal Promotion, Non-personal Promotion and Other Service Types for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by End-user - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users for the Years 2015, 2025 & 2030
• CHINA
  • Pharmaceutical Contract Sales Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 74: China Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Service Type - Percentage Breakdown of Value Sales for Personal Promotion, Non-personal Promotion and Other Service Types for the Years 2015, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by End-user - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users for the Years 2015, 2025 & 2030
• EUROPE
  • Pharmaceutical Contract Sales Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Pharmaceutical Contract Sales Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Service Type - Percentage Breakdown of Value Sales for Personal Promotion, Non-personal Promotion and Other Service Types for the Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by End-user - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users for the Years 2015, 2025 & 2030
• FRANCE
  • Pharmaceutical Contract Sales Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 95: France Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Service Type - Percentage Breakdown of Value Sales for Personal Promotion, Non-personal Promotion and Other Service Types for the Years 2015, 2025 & 2030
  • TABLE 98: France Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: France 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 101: France Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: France Historic Review for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: France 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by End-user - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users for the Years 2015, 2025 & 2030
• GERMANY
  • Pharmaceutical Contract Sales Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Service Type - Percentage Breakdown of Value Sales for Personal Promotion, Non-personal Promotion and Other Service Types for the Years 2015, 2025 & 2030
  • TABLE 107: Germany Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Germany Historic Review for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Germany 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 110: Germany Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Germany Historic Review for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Germany 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by End-user - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Service Type - Percentage Breakdown of Value Sales for Personal Promotion, Non-personal Promotion and Other Service Types for the Years 2015, 2025 & 2030
  • TABLE 116: Italy Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Italy Historic Review for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Italy 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 119: Italy Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Italy Historic Review for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Italy 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by End-user - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Pharmaceutical Contract Sales Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 122: UK Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Service Type - Percentage Breakdown of Value Sales for Personal Promotion, Non-personal Promotion and Other Service Types for the Years 2015, 2025 & 2030
  • TABLE 125: UK Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: UK Historic Review for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: UK 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 128: UK Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: UK Historic Review for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: UK 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by End-user - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Service Type - Percentage Breakdown of Value Sales for Personal Promotion, Non-personal Promotion and Other Service Types for the Years 2015, 2025 & 2030
  • TABLE 134: Spain Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Spain Historic Review for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Spain 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 137: Spain Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Spain Historic Review for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Spain 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by End-user - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Service Type - Percentage Breakdown of Value Sales for Personal Promotion, Non-personal Promotion and Other Service Types for the Years 2015, 2025 & 2030
  • TABLE 143: Russia Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Russia Historic Review for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Russia 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 146: Russia Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Russia Historic Review for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Russia 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by End-user - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Service Type - Percentage Breakdown of Value Sales for Personal Promotion, Non-personal Promotion and Other Service Types for the Years 2015, 2025 & 2030
  • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Rest of Europe Historic Review for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Rest of Europe 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Rest of Europe Historic Review for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Rest of Europe 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by End-user - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Pharmaceutical Contract Sales Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Pharmaceutical Contract Sales Outsourcing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Service Type - Percentage Breakdown of Value Sales for Personal Promotion, Non-personal Promotion and Other Service Types for the Years 2015, 2025 & 2030
  • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Asia-Pacific Historic Review for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Asia-Pacific 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Asia-Pacific Historic Review for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Asia-Pacific 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by End-user - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Pharmaceutical Contract Sales Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Service Type - Percentage Breakdown of Value Sales for Personal Promotion, Non-personal Promotion and Other Service Types for the Years 2015, 2025 & 2030
  • TABLE 173: Australia Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Australia Historic Review for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Australia 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 176: Australia Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Australia Historic Review for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Australia 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by End-user - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users for the Years 2015, 2025 & 2030
• INDIA
  • Pharmaceutical Contract Sales Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 179: India Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Service Type - Percentage Breakdown of Value Sales for Personal Promotion, Non-personal Promotion and Other Service Types for the Years 2015, 2025 & 2030
  • TABLE 182: India Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: India Historic Review for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: India 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 185: India Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: India Historic Review for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: India 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by End-user - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Service Type - Percentage Breakdown of Value Sales for Personal Promotion, Non-personal Promotion and Other Service Types for the Years 2015, 2025 & 2030
  • TABLE 191: South Korea Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: South Korea Historic Review for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: South Korea 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 194: South Korea Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: South Korea Historic Review for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: South Korea 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by End-user - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Service Type - Percentage Breakdown of Value Sales for Personal Promotion, Non-personal Promotion and Other Service Types for the Years 2015, 2025 & 2030
  • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Asia-Pacific Historic Review for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 203: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Rest of Asia-Pacific Historic Review for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Rest of Asia-Pacific 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by End-user - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Pharmaceutical Contract Sales Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Pharmaceutical Contract Sales Outsourcing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Service Type - Percentage Breakdown of Value Sales for Personal Promotion, Non-personal Promotion and Other Service Types for the Years 2015, 2025 & 2030
  • TABLE 212: Latin America Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Latin America Historic Review for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Latin America 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 215: Latin America Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Latin America Historic Review for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Latin America 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by End-user - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Service Type - Percentage Breakdown of Value Sales for Personal Promotion, Non-personal Promotion and Other Service Types for the Years 2015, 2025 & 2030
  • TABLE 221: Argentina Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Argentina Historic Review for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Argentina 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 224: Argentina Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Argentina Historic Review for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Argentina 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by End-user - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Service Type - Percentage Breakdown of Value Sales for Personal Promotion, Non-personal Promotion and Other Service Types for the Years 2015, 2025 & 2030
  • TABLE 230: Brazil Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Brazil Historic Review for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Brazil 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 233: Brazil Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Brazil Historic Review for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Brazil 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by End-user - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Service Type - Percentage Breakdown of Value Sales for Personal Promotion, Non-personal Promotion and Other Service Types for the Years 2015, 2025 & 2030
  • TABLE 239: Mexico Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Mexico Historic Review for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Mexico 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 242: Mexico Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Mexico Historic Review for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Mexico 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by End-user - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Service Type - Percentage Breakdown of Value Sales for Personal Promotion, Non-personal Promotion and Other Service Types for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Latin America Historic Review for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Latin America 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 251: Rest of Latin America Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Latin America Historic Review for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Rest of Latin America 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by End-user - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Pharmaceutical Contract Sales Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Pharmaceutical Contract Sales Outsourcing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Service Type - Percentage Breakdown of Value Sales for Personal Promotion, Non-personal Promotion and Other Service Types for the Years 2015, 2025 & 2030
  • TABLE 260: Middle East Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Middle East Historic Review for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Middle East 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 263: Middle East Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Middle East Historic Review for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Middle East 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by End-user - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Service Type - Percentage Breakdown of Value Sales for Personal Promotion, Non-personal Promotion and Other Service Types for the Years 2015, 2025 & 2030
  • TABLE 269: Iran Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Iran Historic Review for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Iran 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 272: Iran Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Iran Historic Review for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Iran 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by End-user - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Service Type - Percentage Breakdown of Value Sales for Personal Promotion, Non-personal Promotion and Other Service Types for the Years 2015, 2025 & 2030
  • TABLE 278: Israel Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Israel Historic Review for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Israel 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 281: Israel Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Israel Historic Review for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Israel 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by End-user - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Service Type - Percentage Breakdown of Value Sales for Personal Promotion, Non-personal Promotion and Other Service Types for the Years 2015, 2025 & 2030
  • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Saudi Arabia Historic Review for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Saudi Arabia 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 290: Saudi Arabia Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Saudi Arabia Historic Review for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Saudi Arabia 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by End-user - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Service Type - Percentage Breakdown of Value Sales for Personal Promotion, Non-personal Promotion and Other Service Types for the Years 2015, 2025 & 2030
  • TABLE 296: UAE Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: UAE Historic Review for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: UAE 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 299: UAE Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: UAE Historic Review for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: UAE 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by End-user - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Service Type - Percentage Breakdown of Value Sales for Personal Promotion, Non-personal Promotion and Other Service Types for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Middle East Historic Review for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Middle East 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Middle East Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Middle East Historic Review for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Middle East 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by End-user - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users for the Years 2015, 2025 & 2030
• AFRICA
  • Pharmaceutical Contract Sales Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Pharmaceutical Contract Sales Outsourcing by Service Type - Personal Promotion, Non-personal Promotion and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Service Type - Percentage Breakdown of Value Sales for Personal Promotion, Non-personal Promotion and Other Service Types for the Years 2015, 2025 & 2030
  • TABLE 314: Africa Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Africa Historic Review for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Africa 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by Therapeutic Area - Percentage Breakdown of Value Sales for Other Therapeutic Areas, Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases and Infectious Diseases for the Years 2015, 2025 & 2030
  • TABLE 317: Africa Recent Past, Current & Future Analysis for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Africa Historic Review for Pharmaceutical Contract Sales Outsourcing by End-user - Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Africa 15-Year Perspective for Pharmaceutical Contract Sales Outsourcing by End-user - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Medical Device Companies, Generic Companies and Other End-Users for the Years 2015, 2025 & 2030

IV. COMPETITION